Literature DB >> 19167929

Familial aggregation of IgAD and autoimmunity.

Gudmundur H Jorgensen1, Ingunn Thorsteinsdottir, Sveinn Gudmundsson, Lennart Hammarstrom, Bjorn R Ludviksson.   

Abstract

BACKGROUND: The prevalence of autoimmunity is thought to be increased among IgA deficient (IgAD) individuals. However, it is currently unclear if the two conditions coincide within families.
OBJECTIVE: To evaluate the prevalence of autoimmunity among IgAD individuals and their 1 degrees relatives.
MATERIAL AND METHODS: A total of 43 IgAD individuals (32 adults and 11 children) and all available 1 degrees relatives were evaluated by a physician. A family history of autoimmunity was obtained, together with physical examination and a structured questionnaire that focused on symptoms and signs suggestive of autoimmunity.
RESULTS: Eight of the 32 (25%) adult IgAD, were found to have definite autoimmunity, with organ specific- and systemic autoimmune diseases equally distributed. None of the IgAD children had autoimmunity. Among the 1 degrees relatives, 27/269 (10%) had autoimmunity, compared to an estimate of 5% in the general population (p<0.05).
CONCLUSION: Autoimmune diseases are highly prevalent in individuals with IgAD and more common in their 1 degrees relatives than expected, thus, suggesting a possible common genetic component.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167929     DOI: 10.1016/j.clim.2008.11.013

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  12 in total

1.  Health-related quality of life (HRQL) in immunodeficient adults with selective IgA deficiency compared with age- and gender-matched controls and identification of risk factors for poor HRQL.

Authors:  G H Jörgensen; A Gardulf; M I Sigurdsson; S Arnlaugsson; L Hammarström; B R Ludviksson
Journal:  Qual Life Res       Date:  2014-03       Impact factor: 4.147

2.  Clinical symptoms in adults with selective IgA deficiency: a case-control study.

Authors:  G H Jorgensen; A Gardulf; M I Sigurdsson; S Th Sigurdardottir; I Thorsteinsdottir; S Gudmundsson; L Hammarström; B R Ludviksson
Journal:  J Clin Immunol       Date:  2013-02-07       Impact factor: 8.317

3.  Concomitant autoimmunity in myasthenia gravis--lack of association with IgA deficiency.

Authors:  Ryan Ramanujam; Fredrik Piehl; Ritva Pirskanen; Peter K Gregersen; Lennart Hammarström
Journal:  J Neuroimmunol       Date:  2011-06-12       Impact factor: 3.478

4.  Profile of autoantibodies against phosphorylcholine and cross-reactivity to oxidation-specific neoantigens in selective IgA deficiency with or without autoimmune diseases.

Authors:  Ana Elisa Fusaro; Kristine Fahl; Elaine Cristina Cardoso; Cyro Alves de Brito; Cristina M A Jacob; Magda Carneiro-Sampaio; Alberto J S Duarte; Maria Notomi Sato
Journal:  J Clin Immunol       Date:  2010-08-25       Impact factor: 8.317

5.  Selective IgA deficiency: clinical and laboratory features of 118 children in Turkey.

Authors:  Caner Aytekin; Nilden Tuygun; Selim Gokce; Figen Dogu; Aydan Ikinciogullari
Journal:  J Clin Immunol       Date:  2012-05-01       Impact factor: 8.317

Review 6.  Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus.

Authors:  Alexandros P Grammatikos; George C Tsokos
Journal:  Trends Mol Med       Date:  2011-12-15       Impact factor: 11.951

Review 7.  Autoimmunity in immunodeficiency.

Authors:  Krista Todoric; Jessica B Koontz; Daniel Mattox; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

Review 8.  Intestinal immunoregulation: lessons from human mendelian diseases.

Authors:  Fabienne Charbit-Henrion; Marianna Parlato; Georgia Malamut; Frank Ruemmele; Nadine Cerf-Bensussan
Journal:  Mucosal Immunol       Date:  2021-04-15       Impact factor: 7.313

Review 9.  Selective IgA deficiency.

Authors:  Leman Yel
Journal:  J Clin Immunol       Date:  2010-01-26       Impact factor: 8.317

Review 10.  Genetics and autoantibodies.

Authors:  Carlo Perricone; Nancy Agmon-Levin; Fulvia Ceccarelli; Guido Valesini; Juan-Manuel Anaya; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.